179 related articles for article (PubMed ID: 12085968)
21. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
Doll JA; Reiher FK; Crawford SE; Pins MR; Campbell SC; Bouck NP
Prostate; 2001 Dec; 49(4):293-305. PubMed ID: 11746276
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis and prostate cancer: identification of a molecular progression switch.
Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
[TBL] [Abstract][Full Text] [Related]
23. [Anti-angiogenesis strategies in cancer].
Fons P; Malavaud B; Venat L; Plouet J
Bull Acad Natl Med; 2000; 184(3):579-86; discussion 586-7. PubMed ID: 10989554
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic and anti-tumor properties of proteasome inhibitors.
Daniel KG; Kuhn DJ; Kazi A; Dou QP
Curr Cancer Drug Targets; 2005 Nov; 5(7):529-41. PubMed ID: 16305349
[TBL] [Abstract][Full Text] [Related]
25. Role of angiogenesis in tumor growth and metastasis.
Folkman J
Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis in rheumatoid arthritis.
Szekanecz Z; Gáspár L; Koch AE
Front Biosci; 2005 May; 10():1739-53. PubMed ID: 15769663
[TBL] [Abstract][Full Text] [Related]
27. A review on pro- and anti-angiogenic factors as targets of clinical intervention.
Bouïs D; Kusumanto Y; Meijer C; Mulder NH; Hospers GA
Pharmacol Res; 2006 Feb; 53(2):89-103. PubMed ID: 16321545
[TBL] [Abstract][Full Text] [Related]
28. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of ocular angiogenesis and its molecular mediators.
Siemerink MJ; Augustin AJ; Schlingemann RO
Dev Ophthalmol; 2010; 46():4-20. PubMed ID: 20703029
[TBL] [Abstract][Full Text] [Related]
30. Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency.
Khan GN; Merajver SD
Curr Pharm Des; 2007; 13(35):3584-90. PubMed ID: 18220795
[TBL] [Abstract][Full Text] [Related]
31. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
32. The role of angiogenesis in prostate and other urologic cancers: a review.
Izawa JI; Dinney CP
CMAJ; 2001 Mar; 164(5):662-70. PubMed ID: 11258215
[TBL] [Abstract][Full Text] [Related]
33. Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species.
Alcayaga-Miranda F; González PL; Lopez-Verrilli A; Varas-Godoy M; Aguila-Díaz C; Contreras L; Khoury M
Oncotarget; 2016 Jul; 7(28):44462-44477. PubMed ID: 27286448
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in cancer.
Nishida N; Yano H; Nishida T; Kamura T; Kojiro M
Vasc Health Risk Manag; 2006; 2(3):213-9. PubMed ID: 17326328
[TBL] [Abstract][Full Text] [Related]
35. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor expression and angiogenesis in human prostate carcinoma.
Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
[TBL] [Abstract][Full Text] [Related]
37. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis and prostate cancer: important laboratory and clinical findings.
Cox MC; Permenter M; Figg WD
Curr Oncol Rep; 2005 May; 7(3):215-9. PubMed ID: 15847713
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.
Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313
[TBL] [Abstract][Full Text] [Related]
40. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
Ribatti D
Cancer Treat Rev; 2011 Aug; 37(5):344-52. PubMed ID: 21435792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
